June 30, 2016 / 11:12 AM / a year ago

BRIEF-Janssen Inc says Health Canada issued notice of compliance with conditions approving Darzalex

1 Min Read

June 30 (Reuters) - Johnson & Johnson

* Janssen Inc says Health Canada has issued a notice of compliance with conditions approving Darzalex

* Janssen Inc says Darzalex approved by Health Canada for for treatment of multiple Myeloma

* Janssen Inc says product approved on condition that co carries out confirmatory trials to verify clinical benefit of Darzalex Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below